EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Sep 1, 2015
Insider Transaction Report
Form 4
MALFROY-CAMINE BERNARD
Director
Transactions
- Award
Common Stock
2015-08-28+5,570→ 11,525 total - Award
Stock Option (right to buy)
2015-08-28+5,000→ 5,000 totalExercise: $3.59Exp: 2025-08-28→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The Reporting Person received Restricted Shares from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Restricted Shares are not subject to vesting.
- [F2]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option became exercisable as to 25% of the shares underlying the Option on August 28, 2015, 25% of the shares underlying the Option become exercisable on August 28, 2016, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.